David Engelthaler, PhD, MS
Dr. David Engelthaler is an Associate Professor and the Director of TGen North, the infectious disease arm of the non-profit Translational Genomics Research Institute. He currently oversees the TGen North Clinical Laboratory, that was stood up in March 2020 to specifically provide COVID-19 testing and has provided tests for over 56,000 Arizonans and has sequenced over 6,000 strains of SARS-CoV-2. Dr. Engelthaler also oversees a number of research groups working on the development of analytical tools to detect and characterize infectious diseases such as tuberculosis, valley fever, MRSA, and others.
His team at TGen also provides genomic services to CDC and local health departments. He has published 135 scientific papers and chapters on epidemiology, disease ecology, genetics, and microbiology and he has two dozen patented inventions, including assays that received either FDA EUA or 510k clearance.
He received his Masters in Microbiology from Colorado State University and his PhD in Biology at Northern Arizona University. He was previously the Arizona State Epidemiologist and a biologist for the CDC.
Dave has worked in federal, state and local government, and has started for-profit and non-profit businesses. Dave sits on a number of local and national Boards and recently he led the establishment of Flagstaff, AZ as “America’s First STEM City”.
Dr. Engelthaler has no disclosures.